ArticleThe Journal of clinical investigation2010

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.

Laurent Derré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.